BioNTech: Funding, Investors & Team (Oct 2026)
BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
BioNTech has raised $525M across 2 funding rounds on record, the most recent a Post-IPO Equity of $150M announced in Apr 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioNTech Company Profile and Key Stats
Latest funding round on record: Apr 2022.
BioNTech Funding Rounds
BioNTech raised $375M in an undisclosed round announced in Sep 2020.
1.6 years later, a Post-IPO Equity of $150M was announced in Apr 2022.
BioNTech Founders and Leadership Team
Contact details for the BioNTech team: 1 of 1 has an email address on file.
Start 14-day free trial →BioNTech Funding Compared to Other Biotechnology Startups
BioNTech's latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioNTech in Biotechnology and Mainz
Companies Similar to BioNTech
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
BioNTech Funding FAQs
What does BioNTech do?
BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
How much funding has BioNTech raised?
BioNTech has raised $525M across 2 rounds on record. The most recent is a Post-IPO Equity of $150M announced in Apr 2022.
When did BioNTech last raise funding?
BioNTech's most recent funding round on record is a Post-IPO Equity of $150M, announced in Apr 2022.
Who is the CEO of BioNTech?
Ugur Sahin is listed as CEO at BioNTech.
Where is BioNTech headquartered?
BioNTech is based in Mainz, Rheinland-Pfalz, Germany.
How many employees does BioNTech have?
BioNTech is in the 1001-5000 employee band.
How does BioNTech's funding compare to other Biotechnology startups?
BioNTech's latest round of $150M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioNTech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioNTech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.